DaVita Inc. $DVA Shares Acquired by Crossmark Global Holdings Inc.

Key Points

• Crossmark Global Holdings more than doubled its DaVita position in the third quarter, increasing holdings by 116.2% to 33,666 shares worth approximately $5.9 million. Institutional investors collectively own 90.12% of the company.
• Analyst sentiment remains moderately positive: DaVita has four Buy and three Hold ratings, producing a consensus rating of “Moderate Buy” and an average price target of $233.43.
• DaVita reported quarterly EPS of $4.02, beating estimates of $3.88, while revenue rose 5.2% year over year to $3.55 billion. Shares opened at $183.55, below the consensus target and their 52-week high of $247.49.

Crossmark Global Holdings Inc. raised its holdings in DaVita Inc. (NYSE:DVA - Free Report) by 116.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 33,666 shares of the company's stock after purchasing an additional 18,096 shares during the period. Crossmark Global Holdings Inc. owned 0.05% of DaVita worth $5,889,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Value Investment Professionals LLC grew its position in DaVita by 2.0% during the 2nd quarter. Value Investment Professionals LLC now owns 2,501 shares of the company's stock worth $556,000 after acquiring an additional 50 shares during the last quarter. Kesler Norman & Wride LLC boosted its holdings in DaVita by 0.8% in the first quarter. Kesler Norman & Wride LLC now owns 6,816 shares of the company's stock worth $1,048,000 after acquiring an additional 55 shares in the last quarter. State of Alaska Department of Revenue grew its stake in shares of DaVita by 1.9% in the third quarter. State of Alaska Department of Revenue now owns 3,206 shares of the company's stock worth $560,000 after acquiring an additional 60 shares during the period. Northwestern Mutual Wealth Management Co. grew its holdings in shares of DaVita by 4.1% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,915 shares of the company's stock worth $426,000 after acquiring an additional 76 shares during the period. Finally, CoreCap Advisors LLC increased its position in DaVita by 161.7% during the third quarter. CoreCap Advisors LLC now owns 157 shares of the company's stock valued at $27,000 after acquiring an additional 97 shares during the last quarter. 90.12% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research firms have recently commented on DVA. Oppenheimer set a $220.00 price objective on DaVita in a research note on Friday, August 7th. Zacks Research downgraded DaVita from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 6th. Wall Street Zen raised DaVita from a "hold" rating to a "buy" rating in a research report on Saturday, October 17th. Raymond James Financial set a $220.00 target price on shares of DaVita in a research note on Friday, August 7th. Finally, Truist Financial lowered their price objective on shares of DaVita from $250.00 to $215.00 and set a "hold" rating for the company in a research report on Friday, August 7th. Four research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $233.43.

DaVita Price Performance

NYSE DVA opened at $183.55 on Friday. DaVita Inc. has a 1 year low of $101.00 and a 1 year high of $247.49. The company has a market capitalization of $11.71 billion, a PE ratio of 15.02, a P/E/G ratio of 0.48 and a beta of 0.80. The company has a fifty day moving average of $180.60 and a 200 day moving average of $191.69.

DaVita (NYSE:DVA - Get Free Report) last posted its earnings results on Tuesday, August 4th. The company reported $4.02 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.88 by $0.14. The firm had revenue of $3.55 billion during the quarter, compared to analysts' expectations of $3.50 billion. DaVita had a net margin of 6.05% and a negative return on equity of 217.63%. The business's revenue was up 5.2% compared to the same quarter last year. During the same period in the previous year, the business posted $2.95 EPS. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. Research analysts expect that DaVita Inc. will post 14.57 earnings per share for the current year.

DaVita Profile

DaVita Inc NYSE: DVA is a health care services company focused on kidney care. Through its DaVita Kidney Care business, the company provides outpatient dialysis treatments for people with chronic kidney failure, including in-center hemodialysis, home dialysis and related clinical support services.

DaVita also offers integrated kidney care programs intended to support patients across the stages of chronic kidney disease. Its services may include care coordination, disease management, education, transplant support and other services designed to improve clinical outcomes and help manage the needs of patients with complex kidney conditions.

The company operates a network of dialysis centers and related facilities in the United States and serves patients in select international markets.

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.